The development of Biopolis was undertaken in 5 phases.

 

Phase 1 cost S$500 million to build and was launched in 2003. It provides 200,000sqm of research space which is now home to more than 2,000 scientists, researchers, technicians and administrators. The research community is fully supported by state-of-the-art infrastructure and services catering to the full spectrum of biomedical R&D activities.

 

Phase 2 was officially opened in 2006. The additional 37,000sqm of built-up area comprises two buildings – Neuros and Immunos.

 

Phase 3 was completed in January 2011. The 41,500sqm facility is set to tap on the synergies of the Biopolis cluster and support world-class research programmes in clinical and translational research as well as medical technology research.

 

Development for phases 4 and 5 are currently underway and slated to be completed in 2013. Phase 4 has been taken up by Procter & Gamble for its Singapore Innovation Centre, whilst Phase 5 will provide 46,182sqm of biomedical research facility for additional laboratory space, including ready-fitted laboratories (i.e. Shell-plus laboratory) which caters to biomedical SMEs and start-ups through saving the companies time and resources during their initial setup phase.